The synthesis and initial biological evaluation of a calixarene-based inhibitor for cholera toxin has been developed

Chairman of the German Association of Biotechnology Industries (DIB; Deutsche Industrievereinigung Biotechnologie) reported on trends and demands

BODIPY–tetrazine derivatives as superbright bioorthogonal turn-on probes

Hemagglutinin-based nanoparticles are a novel generation of vaccines against influenza

Sulfa drugs elicit neurological adverse effects because they interfere with L-3,4-dihydroxyphenylalanine synthesis

Thomas Buchler, CEO of the quinine producer Buchler & Co., talks about the ups and downs of the international cinchona trade

Professor Uwe Bornscheuer talks about his exciting field of research, biocatalysis and protein engineering, and his broad experience in publishing

The immune drug AS10 protects the ovaries from the toxic effects exerted by the chemotherapeutic agent cyclophosphamide

Poly(lactic-co-glycolic acid) nanoparticles wrapped with red blood cell membranes neutralize pore-forming toxins

Biological activity of small-molecule RNA polymerase (RNAP) inhibitors revealed to come from polymeric impurity